-transparent.png){kind=logo}
This paper reports some new structural modifications (branching and lengthening of alkanoic substituent, increase of heterocycle-carboxylate distance) on 1,2,3-triazole derivative 1, a potent in vitro inhibitor of prostaglandin synthesis, and their influence on enzyme activity. Regarding the structural relationship between 1 and Dazoxiben, a selective thromboxane-synthetase inhibitor, the preparation and activity of some Dazoxiben analogs bearing different heterocycles, are also described.
Related Publications
G Biagi, and
G Dell'Omodarme, and
M Ferretti, and
I Giorgi, and
O Livi, and
V Scartoni, and
E Tiscione
August 1986,
Il Farmaco; edizione scientifica,
G Biagi, and
G Dell'Omodarme, and
M Ferretti, and
I Giorgi, and
O Livi, and
V Scartoni, and
E Tiscione
April 1987,
Il Farmaco; edizione scientifica,
G Biagi, and
G Dell'Omodarme, and
M Ferretti, and
I Giorgi, and
O Livi, and
V Scartoni, and
E Tiscione
December 2018,
Bioorganic chemistry,
G Biagi, and
G Dell'Omodarme, and
M Ferretti, and
I Giorgi, and
O Livi, and
V Scartoni, and
E Tiscione
January 2021,
Bioorganic & medicinal chemistry,
G Biagi, and
G Dell'Omodarme, and
M Ferretti, and
I Giorgi, and
O Livi, and
V Scartoni, and
E Tiscione
October 2022,
Pharmaceuticals (Basel, Switzerland),
G Biagi, and
G Dell'Omodarme, and
M Ferretti, and
I Giorgi, and
O Livi, and
V Scartoni, and
E Tiscione
January 2020,
Frontiers in pharmacology,
G Biagi, and
G Dell'Omodarme, and
M Ferretti, and
I Giorgi, and
O Livi, and
V Scartoni, and
E Tiscione
February 1985,
Il Farmaco; edizione scientifica,
G Biagi, and
G Dell'Omodarme, and
M Ferretti, and
I Giorgi, and
O Livi, and
V Scartoni, and
E Tiscione
August 1993,
Farmaco (Societa chimica italiana : 1989),
G Biagi, and
G Dell'Omodarme, and
M Ferretti, and
I Giorgi, and
O Livi, and
V Scartoni, and
E Tiscione
January 2021,
Current organic synthesis,
G Biagi, and
G Dell'Omodarme, and
M Ferretti, and
I Giorgi, and
O Livi, and
V Scartoni, and
E Tiscione
November 2020,
Molecular diversity,
